The U.S. Food and Drug Administration (FDA) has accepted for filing PTC Therapeutics’ New Drug Application (NDA) for ...

Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), has signed a multi-year ...

Biogen receives exclusive rights to commercialize zorevunersen outside U.S., Europe, and Japan.

Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, and CEO-Partner of Flagship Pioneering, a bioplatform innovation company.

The U.S. Food and Drug Administration (FDA) has granted Priority Review to Boehringer Ingelheim’s new drug application for zongertinib (BI 1810631) for the treatment of adult patients with ...

Seqens, a developer and producer of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, has named Pascal Villemagne as Chief Executive Officer, effective April ...

The U.S. Food and Drug Administration (FDA) has approved for review a Biologics License Application (BLA) for AVT06, Alvotech ...

Flourish Research, a multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and ...

TekniPlex, an advanced materials science company, has named long-tenured senior executive Suj Mehta as CEO of its Healthcare ...

Asahi Kasei Bioprocess America Inc. (AKBA), a leader in advanced filtration and fluid management solutions for the ...

Arcus Biosciences, Inc. has regained ownership of casdatifan, a potential treatment for clear cell renal cell carcinoma (ccRCC), after Gilead’s time-limited exclusive option rights to casdatifan ...

The US Food and Drug Administration (FDA) has accepted for priority review Sanofi’s supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid ...